Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

No data on intermediate 1-(5,7-dihydro-4H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine triflate. The available information is for the free base.

Oral-dose studies in mice, rats, and dogs over durations of 28 days, 6 and 9 months, respectively are available.

In mice, the substance (≤100 mg/kg/day) was generally well tolerated except for limited mortality in females. In rats and dogs, there were clinical observations consistent with CNS activity including dilated pupils (dogs only), increased or decreased activity, impaired coordination, hypersensitivity to touch, salivation, vocalization, lacrimation, and tremor. Convulsions were sporadically noted at >60 mg/kg/day in rats and at 15 mg/kg/day as single instance of self-limiting intermittent convulsions in a female dog.

In rats, low body weight gains were noted throughout the dosing period.

In dogs, an increased incidence and severity of clinical observations consistent with CNS activity occurred at ≥2.5 mg/kg/day.

The NOAELs were 100 and 50 mg/kg/day in male and female mice, 15 mg/kg/day in rats, and 10 mg/kg/day in dogs.

Key value for chemical safety assessment

Toxic effect type:
dose-dependent

Additional information

Justification for classification or non-classification